Innova Captab Share Price Target 2026 Analyst Forecast Bull and Bear Case

The Innova Captab share price target 2026 is Rs 1,150, based on analyst estimates and the FY27 earnings recovery thesis for Innova Captab (NSE: INNOVACAP). Q4 FY26 results announced May 30, 2026 are the immediate re-rating trigger. This article covers the complete Innova Captab share price target analysis including sector tailwinds, peer context, key risks, and bull and bear case scenarios.

Click Here – Get Free Investment Predictions

Innova Captab Share Price Target 2026: Key Takeaways

• Innova Captab share price target 2026: Rs 1,150 (20% upside from CMP Rs 956.65)
• Bull case: Rs 1,400 | Bear case: Rs 765
• Ticker: INNOVACAP | Sector: Contract Pharmaceutical Manufacturing | MCap: Rs 3,826 crore
• 52W range: Rs 622 to Rs 1,339 | PE: 28x
• Key catalyst: Q4 FY26 results confirming FY27 earnings recovery
• Key risk: FY27 earnings miss or sustained FII outflows

Innova Captab Company Overview

Innova Captab (NSE: INNOVACAP) is a Baddi-based pharma CDMO manufacturing tablets, capsules, dry syrups, and liquid formulations for Indian pharma companies and for institutional supply to state health departments, listed August 2023, with FY26 revenue of Rs 1,400 crore. At CMP Rs 956.65 against a 52 week range of Rs 622 to Rs 1,339, the stock trades at a discount to its 52 week high. Market capitalisation is Rs 3,826 crore with trailing PE of 28x. Compared to peers in pharma CDMO like Divi’s Laboratories and Suven Pharma, Innova Captab is positioned as a potential re-rating candidate toward the Innova Captab share price target of Rs 1,150.

Parameter	Value
NSE Ticker	INNOVACAP
Sector	Contract Pharmaceutical Manufacturing
CMP (May 30, 2026)	Rs 956.65
52 Week High	Rs 1,339
52 Week Low	Rs 622
Market Cap	Rs 3,826 crore
Trailing PE	28x
12-Month Analyst Target	Rs 1,150
Bull Case Target	Rs 1,400
Bear Case Target	Rs 765

Why Is the Innova Captab Share Price Target Set at Rs 1,150 for 2026

FY27 Earnings Delivery and Revenue Acceleration

The Innova Captab share price target 2026 of Rs 1,150 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results confirming the earnings recovery trajectory are the most direct catalyst for re-rating from CMP Rs 956.65 toward Rs 1,150.

Structural Sector Tailwinds in Contract Pharmaceutical Manufacturing

The Contract Pharmaceutical Manufacturing sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising investment. Innova Captab’s market position among peers in pharma CDMO like Divi’s Laboratories and Suven Pharma creates a structural growth runway supporting the Innova Captab share price target of Rs 1,150 and bull case of Rs 1,400.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle, commencing early 2026, reduces Innova Captab’s borrowing costs and stimulates end market demand. Lower interest costs improve EPS trajectory, directly supporting the Innova Captab share price target of Rs 1,150.

Union Budget 2026-27 Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a positive policy backdrop for Innova Captab’s Contract Pharmaceutical Manufacturing operations, improving the probability of achieving the Innova Captab share price target of Rs 1,150.

Improving FII Flows Post the April 2026 Tariff Shock

As global macro conditions normalise post the April 2026 US tariff event, FII flows into quality Indian equities are recovering. At 28x PE, Innova Captab is positioned as a beneficiary of institutional reallocation toward the Innova Captab share price target of Rs 1,150.

Innova Captab Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Innova Captab Share Price Target: 3 to 6 Months

The near-term Innova Captab share price target is anchored to support near the 52 week low of Rs 622. A confirmed Q4 FY26 earnings recovery is the trigger for an initial 10 to 15 percent re-rating toward Rs 1,150.

12-Month Innova Captab Share Price Target 2026

The 12-month Innova Captab share price target 2026 is Rs 1,150, implying approximately 20 percent upside from CMP Rs 956.65. Track live on NSE ticker INNOVACAP.

Long Term Innova Captab Share Price Target: FY27 to FY28

For investors with a 2 to 3 year horizon, the long-term Innova Captab share price target is Rs 1,400 in the bull case, assuming full earnings delivery and sector re-rating among peers in pharma CDMO like Divi’s Laboratories and Suven Pharma.

Bull Case and Bear Case for the Innova Captab Share Price Target

Bull Case Innova Captab Share Price Target: Rs 1,400

The bull case of Rs 1,400 materialises when FY27 earnings beat estimates, Contract Pharmaceutical Manufacturing tailwinds accelerate, and FII flows return strongly, enabling re-rating toward higher peer multiples.

Bear Case Innova Captab Share Price Target: Rs 765

The bear case of Rs 765 materialises if FY27 earnings disappoint and FII outflows persist, with the stock approaching the 52 week low of Rs 622.

Scenario	Target	Key Conditions
Bull Case	Rs 1,400	FY27 earnings beat, re-rating, FII inflows
Base Case	Rs 1,150	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 765	FY27 miss, guidance cut, FII outflows

Key Risks to the Innova Captab Share Price Target 2026

US Tariff and Global Macro Risk

Prolonged US tariff tension remains a key macro risk to the Innova Captab share price target 2026 of Rs 1,150.

Valuation and Earnings Miss Risk

Any FY27 earnings miss or guidance cut could compress multiples, posing the most direct risk to the Innova Captab share price target of Rs 1,150.

Competitive Pressure in Contract Pharmaceutical Manufacturing

Intensifying competition among peers in pharma CDMO like Divi’s Laboratories and Suven Pharma could compress Innova Captab’s pricing power, a structural risk when evaluating the Innova Captab share price target of Rs 1,150.

FII Selling Pressure and Liquidity Risk

Sustained FII outflows can delay re-rating toward the Innova Captab share price target of Rs 1,150 regardless of company-level improvement through FY27.

How to Invest in Innova Captab

Check the Univest Screener for live data

Begin by reviewing Innova Captab’s Q4 FY26 results, annual report, and FY27 guidance before forming a view on the Innova Captab share price target of Rs 1,150. Focus on revenue growth, margin trends, and management commentary on Contract Pharmaceutical Manufacturing sector opportunities.

Open a Demat and trading account with a SEBI registered stockbroker to buy Innova Captab (NSE: INNOVACAP) with full regulatory protection. Understand the competitive dynamics among peers in pharma CDMO like Divi’s Laboratories and Suven Pharma before executing any position.

Plan your entry near the 52 week low support of Rs 622. A confirmed Q4 FY26 earnings uptick and positive FY27 guidance strengthen the entry case for the Innova Captab share price target of Rs 1,150. Set a disciplined stop loss below the 52 week low.

Restrict any single stock to 3 to 5 percent of your total equity portfolio to manage concentration risk in the Contract Pharmaceutical Manufacturing space where sectoral cycles can amplify volatility.

Always consult a SEBI registered financial advisor before investing based on any Innova Captab share price target estimate. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Innova Captab’s live price and get daily stock recommendations.

FAQs on Innova Captab Share Price Target 2026

What is the Innova Captab share price target for 2026?

Ans. The Innova Captab share price target 2026 is Rs 1,150, implying approximately 20 percent upside from CMP Rs 956.65. Bull case is Rs 1,400, bear case is Rs 765.

What is the Innova Captab share price target for 2025?

Ans. The Innova Captab share price target for 2025 was based on FY26 earnings projections. The current 2026 analyst target is Rs 1,150, reflecting FY27 growth potential from CMP Rs 956.65.

Is Innova Captab a good buy at Rs 956.65?

Ans. At Rs 956.65, Innova Captab offers potential upside to the share price target of Rs 1,150 if FY27 earnings recover. Consult a SEBI registered financial advisor before investing.

What is the 52 week high and low of Innova Captab?

Ans. The 52 week high of Innova Captab is Rs 1,339 and the 52 week low is Rs 622. At CMP Rs 956.65, the stock offers upside toward the 12-month share price target of Rs 1,150.

What are the key risks to the Innova Captab share price target?

Ans. Key risks include FY27 earnings miss, US tariff-driven FII outflows, competitive pressure among peers in pharma CDMO like Divi’s Laboratories and Suven Pharma, and broader market volatility.

What are the catalysts for the Innova Captab share price target?

Ans. Primary catalysts include FY27 PAT recovery, Contract Pharmaceutical Manufacturing tailwinds, RBI rate cut support, Budget 2026-27 policy uplift, and FII flow normalisation into Indian equities.

How does Innova Captab compare to its peers?

Ans. Innova Captab operates in Contract Pharmaceutical Manufacturing alongside peers in pharma CDMO like Divi’s Laboratories and Suven Pharma. At CMP Rs 956.65 with MCap Rs 3,826 crore, the company is a potential re-rating candidate toward the share price target of Rs 1,150.

What is the Innova Captab share price target for 2027?

Ans. The long-term Innova Captab share price target for FY27 to FY28 is Rs 1,400 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.